Browse by Medical Category
Call to request an appointment or refer a patient:
The Barrett's Esophagus Treatment Center at Massachusetts General Hospital is one of the few multidisciplinary programs in the nation dedicated to providing comprehensive diagnosis and treatment of Barrett's esophagus. Our team includes gastroenterologists, surgeons, pathologists and nurses with longstanding expertise in medical, endoscopic and surgical management of Barrett's esophagus.
In the United States, an estimated 3.3 million adults over age 50 suffer from Barrett’s esophagus, a condition affecting the lining of the esophagus. The most important step in the treatment of the condition is early diagnosis. Gastrointestinal pathologists in the Mass General Barrett’s Esophagus Treatment Center are experts in using advanced endoscopic diagnostic techniques to identify Barrett's esophagus.
Depending on the patient’s history and symptoms, the Barrett's Esophagus Treatment Center team may recommend one or more of the following diagnostic evaluations:
Barrett's esophagus is the most important risk factor for the development of esophageal adenocarcinoma, a cancer that is growing in incidence faster than any other in the U.S. Though the overall risk of developing esophageal cancer is low, we carefully monitor patients with dysplasia, a precancerous stage of Barrett's esophagus.
Read answers to frequently asked questions about Barrett's esophagus, including its causes and diagnosis.
The Barrett's Esophagus Treatment Center team recommends personalized treatment options based on each patient’s condition. Many people with Barrett’s esophagus also have chronic acid reflux or gastroesophageal reflux disease (GERD). All treatment plans optimize medical management of GERD with antacid oral medications and lifestyle modifications. Most treatment options performed by the Mass General team are minimally invasive. Recommended treatment may include:
The Barrett's Esophagus Treatment Center works closely with colleagues in the Mass General Cancer Center and patients can be referred there for further treatment if necessary.
Physicians of the Mass General Barrett's Esophagus Treatment Center have had a longstanding research interest in Barrett's esophagus. Our mission is to enhance the treatment and prevention of Barrett's esophagus by improving our understanding of the disease’s cause and its progression to cancer. We are actively enlisting our patients to establish a Barrett’s esophagus Patient Registry (BPR), which will house data, serum and tissue for the purposes of genomic and biomarker discovery. Our clinicians’ research includes efforts to:
Read answers to frequently asked questions about Barrett's esophagus, including causes, diagnosis and treatment
Barrett's esophagus is a condition in which normal cells that line the esophagus turn into cells not usually found in humans called “specialized columnar cells.”
Esophageal cancer is cancer that develops in the esophagus, the muscular tube that connects the throat to the stomach.
Gastroesophageal reflux disease (GERD) is a digestive disorder that is caused by gastric acid flowing from the stomach into the esophagus.
Gastroparesis is a stomach disorder in which the stomach takes too long in emptying its contents.
Halitosis is an oral health condition characterized by consistently odorous breath.
H. pylori is a spiral-shaped bacterium found in the stomach, which (along with acid secretion) damages stomach and duodenal tissue, causing inflammation and peptic ulcers.
A hiatal hernia occurs when the upper part of the stomach pushes up into the chest through a small opening in the diaphragm, the muscle that separates the stomach from the chest.
Indigestion, also known as dyspepsia, is a painful or burning feeling in the upper abdomen and is usually accompanied by nausea, bloating or gas, a feeling of fullness, and, sometimes, vomiting.
An ulcer is an open sore, or lesion, usually found on the skin or mucous membrane areas of the body.
Stomach cancer, also known as gastric cancer, is cancer that starts in any part of the stomach.
A new capsule-like device may provide an alternative screening method for Barrett’s esophagus and esophageal cancer.
Physicians can help stem the rising incidence of gastroesophageal cancers by aggressively treating patients with gastroesophageal reflux (GERD) and Barrett's esophagus.
Endoscopic mucosal resection (EMR) is a specialized endoscopic technique used by gastroenterologists at the Massachusetts General Hospital Digestive Healthcare Center to diagnose and remove large areas of early gastrointestinal cancers.
Barrett’s Esophagus Treatment Center
Back to Top